Device for serological investigation of yersinia infections and/or subsequent illnesses and use of proteins MyfA and PsaA of Y enterocolitica and Y. pseudotuberculosis as recombinant antigens
EP2023142A1
Immunoassay utilizing recombinant nucleocapsid-proteins for detection of antibodies to human coronaviruses
EP1970708A1
Bio chip and method for selective proof of Chlamydia trachomatis infections
EP1933153A1
Test system for parallel conduct of multi-parameter evidence reactions
DE10307517A1
Peptides derived from capsid antigens of the Epstein-Barr virus and their use
DE19910045A1
Method for determining the avidity of antibodies
US6274307B1
Immunologically active peptides or polypeptides from the parvovirus B19
DE19632862A1
Immunologically active proteins of Borrelia burgdorferi, nucleic acids coding for them as well as their use in test kits and as vaccines
DE4041304A1
POLYPEPTIDES DERIVED FROM STRUCTURAL PROTEINS OF HEPATITIS C-VIRUS, TEST KITS CONTAINING THESE POLYPEPTIDES AND VACCINE AGAINST INFECTIONS FROM HEPATITIS C VIRUSES
AU7058691A
Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine
DE4018988A1
Borrelia burgdorferi immunologically active proteins, test kits containing these proteins and suitable for detecting antibodies in test liquids, monoclonal antibodies directed against the immunologically active proteins and the use of these proteins as vaccines against infections caused by Borrelia strains
DE4003826A1
Peptides of the capsid proteins VP1 or VP2 of the parvovirus B19
